According to the company, the AccuVax Vaccine Management System streamlines vaccine workflow, saves nursing time, minimizes vaccine waste, safeguards vaccine potency, and helps protect against medical errors.
Vaccines are one of the most significant public health successes. Yet, lapses in handling can render a vaccine ineffective and may leave people unprotected or needing revaccination, according to the Centers for Disease Control and Prevention.
Inventory losses due to power failure, improper storage and expired doses are common, and have created challenges for even the most advanced practices and health systems.
According to the company, AccuVax offers key advantages over conventional vaccine refrigeration and storage practices.
The system automates time-consuming storage, handling, and documentation tasks. It also dramatically simplifies compliance with CDC guidelines, as well as the requirements of the federally funded vaccine program.
AccuVax is the purpose-built vaccine supply management system that automates product control and integrity, minimises risks of incorrect vaccine delivery, and optimises office work flow so that providers can focus on care delivery.
It is an integrated solution that includes hardware, software, online access, software updates, training, optional integrations, technical support and maintenance.
TruMed Systems, a medical technology company developing innovative point-of-care supply management systems for healthcare professionals.
Valneva reports positive final Phase 2 results for Lyme disease vaccine VLA15
Lunai Bioworks receives first LOI to license next-generation immune cell therapy
BioNet receives positive opinion from EMA for VacPertagen marketing authorisation in EU
Anixa Biosciences secures U.S. Patent strengthening breast cancer vaccine IP into mid 2040s
PharmaJet® and EVA Pharma Partner to Scale Needle-free Polio Immunisation Across Egypt
Frontier IP portfolio company achieves breakthrough in livestock vaccine trials
GC Biopharma's Phase 2 clinical trial results for BARYTHRAX published in Vaccine
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses
Zoetis announces EU approval for Portela to relieve osteoarthritis pain in cats
4basebio synthetic DNA used in Phase I/II mRNA therapy trial
Arcturus reports interim Phase 2 data for ARCT-032 in cystic fibrosis
Sanofi reports data showing high-dose flu vaccine delivers superior protection for older adults
GC Biopharma granted CMO rights for Curevo Vaccine's shingles vaccine